Control Bionics is positioned as a clinically validated assistive communication company leveraging EMG-based interfaces to enable interaction for patients with severe motor impairment. Its FDA-cleared systems and long operating history place it among the more mature players in non-invasive assistive neurotech, though its technology is evolutionary rather than paradigm-shifting.